120 related articles for article (PubMed ID: 6474418)
1. Impaired function of TXA2 and/or calcium in the platelets from SHRSP at hypertensive ages.
Tomita T; Umegaki K; Nakamura K; Hayashi E
Thromb Res; 1984 Jul; 35(2):219-30. PubMed ID: 6474418
[TBL] [Abstract][Full Text] [Related]
2. Hypoaggregability of washed platelets from stroke-prone spontaneously hypertensive rats (SHRSP).
Tomita T; Umegaki K; Hayashi E
Stroke; 1984; 15(1):70-5. PubMed ID: 6420947
[TBL] [Abstract][Full Text] [Related]
3. Primary dysfunction in aggregation and secretion of SHRSP platelets: not secondary to the circulation of "exhausted" platelets.
Umegaki K; Nakamura K; Tomita T
Blut; 1986 Jan; 52(1):17-27. PubMed ID: 3632911
[TBL] [Abstract][Full Text] [Related]
4. Defective protein phosphorylation associated with hypofunctions in stroke-prone spontaneously hypertensive rat platelets.
Tomita T; Ikeda M; Inoue Y; Mitubori T; Umegaki K
Hypertension; 1989 Sep; 14(3):304-15. PubMed ID: 2504671
[TBL] [Abstract][Full Text] [Related]
5. Defective calcium transport in platelets from stroke-prone spontaneously hypertensive rats.
Umegaki K; Ikeda M; Tomita T
Thromb Res; 1986 Feb; 41(3):415-23. PubMed ID: 3705015
[TBL] [Abstract][Full Text] [Related]
6. Reduced functions of intracellular Ca2+ in aggregation, secretion and protein phosphorylation of permeabilized platelets from stroke-prone spontaneously hypertensive rats.
Ikeda M; Onda T; Tomita I; Tomita T
Thromb Res; 1992 Sep; 67(6):655-63. PubMed ID: 1440531
[TBL] [Abstract][Full Text] [Related]
7. Platelet Ca2+ is not increased in stroke-prone spontaneously hypertensive rats: comparative study with spontaneously hypertensive rats.
Ono N; Oshima T; Ishida M; Ishida T; Matsuura H; Kambe M; Kajiyama G
Hypertension; 1996 Jun; 27(6):1312-7. PubMed ID: 8641741
[TBL] [Abstract][Full Text] [Related]
8. Defects of thrombin-induced protein phosphorylation in platelets from stroke-prone spontaneously hypertensive rats.
Umegaki K; Ikeda M; Nakamura K; Tomita T
FEBS Lett; 1986 Feb; 196(1):139-44. PubMed ID: 3943626
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid metabolism in platelets from stroke-prone spontaneously hypertensive rats and Wistar Kyoto rats.
Ikeda M; Onda T; Mitsubori T; Umegaki K; Tomita I; Tomita T
J Pharmacobiodyn; 1992 Feb; 15(2):49-57. PubMed ID: 1328596
[TBL] [Abstract][Full Text] [Related]
10. Changes in Ca2+ mobilization in platelets from stroke-prone spontaneously hypertensive rats.
Higashino H; Suzuki A
Clin Exp Hypertens; 1994 Jan; 16(1):89-103. PubMed ID: 8136778
[TBL] [Abstract][Full Text] [Related]
11. Basic aggregation properties of washed rat platelets: correlation between aggregation, phospholipid degradation, malondialdehyde, and thromboxane formation.
Tomita T; Umegaki K; Hayashi E
J Pharmacol Methods; 1983 Aug; 10(1):31-44. PubMed ID: 6632921
[TBL] [Abstract][Full Text] [Related]
12. Changes in free calcium concentrations in platelets of SHRSP and WKY: its relationship to ATP releasing potencies and platelet aggregation activities upon stimulation of several reagents.
Higashino H; Suzuki A
Clin Exp Hypertens A; 1991; 13(5):719-33. PubMed ID: 1773505
[TBL] [Abstract][Full Text] [Related]
13. Changes in platelet function due to hypertension: comparison of experimental hypertension with spontaneous hypertension in rats.
Umegaki K; Nakamura K; Ikeda M; Inoue Y; Tomita T
J Hypertens; 1989 Jan; 7(1):13-9. PubMed ID: 2708809
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats.
Stier CT; Benter IF; Levine S
Stroke; 1988 Sep; 19(9):1145-50. PubMed ID: 3413813
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation.
Huzoor-Akbar ; Anwer K
Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet activation in stroke-prone spontaneously hypertensive rats: comparison of losartan, candesartan, and valsartan.
Jiménez AM; Montón M; García R; Núñez A; Gómez J; Rico L; García-Colis E; de Miguel LS; Arriero MM; Cabestrero F; Farré J; Casado S; López-Farré A
J Cardiovasc Pharmacol; 2001 Apr; 37(4):406-12. PubMed ID: 11300653
[TBL] [Abstract][Full Text] [Related]
17. Normal thrombin binding leads to greater fibrinogen binding and increased platelet aggregation in spontaneously hypertensive rats.
Huzoor-Akbar ; Kundu N; Kornhauser R
Life Sci; 1993; 53(26):1967-74. PubMed ID: 8255159
[TBL] [Abstract][Full Text] [Related]
18. Renal prostaglandins and phospholipase A2 in spontaneously hypertensive rats.
Kawaguchi H; Saito H; Yasuda H
J Hypertens; 1987 Jun; 5(3):299-304. PubMed ID: 3302039
[TBL] [Abstract][Full Text] [Related]
19. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
20. Intralymphocytic free calcium and magnesium in stroke-prone spontaneously hypertensive rats and effects of blood pressure and various antihypertensive agents.
Adachi M; Nara Y; Mano M; Ikeda K; Horie R; Yamori Y
Clin Exp Pharmacol Physiol; 1993 Sep; 20(9):587-93. PubMed ID: 8222339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
